To evaluate the prognostic role of pulmonary venous flow parameters and their role in patients with preserved ejection fraction (EF).
Introduction
Pulmonary venous flow measurements include the peak systolic (S) velocity, peak diastolic (D) velocity, the duration of the atrial regurgitant (Ar) velocity, the S/D ratio (peak and integral) and the time difference between the Ar velocity and mitral A-wave duration. The recent Joint of Diastology Working Group has granted only a minor and supporting role for pulmonary venous flow parameters in diastolic grading in patients with preserved ejection fraction (EF). 1 The secondary role ascribed to the pulmonary venous flow measurements was attributed to several factors including difficulty in obtaining high-quality recordings suitable for measurements, and the small number of studies showing the prognostic role of pulmonary venous flow, 2 -4 all in patients with low EF.
In this study, we aimed to analyse the additive prognostic value of assessment of pulmonary venous flow measurements performed as part of routine echo practice in a large group of patients with preserved EF and normal sinus rhythm. Furthermore, we analysed whether the inclusion of those measurements may influence the diastolic grading process.
Material and methods

Study design
The study population included only in-hospital patients admitted for numerous causes including cardiological and systemic diagnoses to a tertiary hospital (Tel Aviv Medical Center) between January 2012 and January 2013. The frequency of treated hypertension was 41%, of known heart failure 20%, chronic kidney disease 21%, chronic lung disease 6%, and coronary artery disease 25%. The study cohort included only patients with preserved EF (.50%), normal sinus rhythm, without significant mitral disease (mitral regurgitation ≥moderate, any degree of mitral stenosis), pericardial or endocardial disease, severe co-morbid or life-limiting conditions (metastatic cancer, end-stage lung disease, cirrhosis, or end-stage renal disease) at presentation in which routine diastolic assessment including pulmonary venous flow estimation was performed by a single sonographer (E.E.) during routine echo practice (not part of research protocols). Thus, all patients had sinus rhythm, preserved EF, and no cardiac or systemic co-morbidities that may interfere with diastolic assessment or outcome analysis. Outcome was analysed from the date of echo evaluation until death or last follow-up.
Baseline clinical assessment and management
Patients' symptoms and co-morbid conditions summarized as the Charlson age-adjusted co-morbidity index 5 were evaluated by the patients' Tel
Aviv Medical Centre personal physician. Congestive heart failure (CHF) at baseline, or heart failure hospitalizations were defined based on the following: presence of at least two major criteria or one major criterion with two minor criteria. Major criteria included paroxysmal nocturnal dyspnoea, neck -vein distention, rales, cardiomegaly, pulmonary oedema, S3 gallop, hepatojugular reflux, or laboratory evidence of visceral congestion. Minor criteria included ankle oedema, dyspnea on exertion, hepatomegaly, pleural effusion, or tachycardia (,120/min). 6, 7 Clinical management was determined independently by the patients and their personal physicians using all information available.
Follow-up and outcomes
Clinical follow-up was obtained by review of medical records, and surveys. Cause of death was determined by review of all medical records and death certificates. Events used as end points were admission for heart failure exacerbation and cardiovascular events. Cardiovascular events comprised cardiac death including sudden death, CHF, new onset of atrial fibrillation but not death due to other causes.
Doppler-echocardiography
Ejection fraction was calculated by the Quinones method, and LV diameters, inter-ventricular septal and posterior wall width, LV mass, relative wall thickness, were calculated as recommended. 8 Forward stroke volume was calculated from left ventricular outflow tract with subsequent calculation of cardiac output and index. Valvular function was assessed by standard qualitative assessment using jet size according to the guidelines (normal/trivial ¼ 1, mild ¼ 2, moderate ¼ 3, severe ¼ 4). 9 Early (E) and atrial (A) trans-mitral flow velocities, and early diastolic mitral annular velocity (e ′ ) were measured in the apical 4-chamber view.
1,10 A wave duration was measured at the level of the mitral annulus as previously recommended. 11 The e ′ was measured from septal and lateral annulus. The ratio of peak E to peak e ′ (septal, lateral, and average) was calculated (mitral E/e ′ ratio) from the average of at least three cardiac cycles. Left atrial volume was calculated using the biplane area length method at end systole. 8 Pulmonary venous flow assessment PW Doppler of pulmonary venous flow was performed as part of routine practice using the apical 4-chamber view as recommended by recent guidelines. Colour flow imaging was used for the proper location of the sample volume in the right upper pulmonary vein usually by angulating the transducer superiorly such that the aortic valve was seen. A 2 -3-mm sample volume was placed 0.5 cm into the pulmonary vein for optimal recording of the spectral waveforms. Wall filter settings were set low enough to display the onset and cessation of the atrial reversal (Ar) velocity waveform. The spectral recordings were obtained at a sweep speed of 50-100 mm/s at end-expiration and included the average of three consecutive cardiac cycles. Measurements of pulmonary venous waveforms included peak and velocity time integral (VTI), systolic (S) velocity, peak and VTI antero-grade early diastolic (D) velocity, the calculated S/D peak, and S/D VTI ratio, the duration of the Ar velocity, and the time difference between it and mitral A-wave duration.
Statistics
Descriptive results were expressed as mean + SD for continuous variables and as percentages for categorical variables. Group comparisons used ANOVA, the Fisher's exact test, or x 2 test, as appropriate. Multiple comparisons for continuous and categorical parameters used the Tukey-Kramer honestly significant difference test and the Bonferroni correction, respectively. Clinical end points were time to heart failure readmissions and time to combined cardiac event (cardiac death, or heart failure readmission). Cox proportional hazards models for the end points allowed calculation of hazard ratios (HR) attached to pulmonary vein flow parameters and were used unadjusted and adjusted for diastolic grade, age, left atrial volume index and E/e ′ (average and septal). Incremental value of pulmonary vein flow parameters vs. diastolic grading and comparison of the different pulmonary venous parameters for assessment of time to clinical end points were tested by comparing nested models with F-tests. P values ,0.05 were considered significant. All authors participated in designing the study, collecting and analysing data, and drafting and revising the manuscript.
Results
Baseline characteristics
All echo exams were performed as part of the routine echo practice and the median duration of exams was 25 [19, 34] min. Out of 541 patients with preserved EF, 50 patients were excluded due to atrial fibrillation, 57 excluded due to significant mitral diseases (interfering with diastolic assessment), 26 due to metastatic cancer, and 15 due to end-stage lung disease, cirrhosis, or end-stage renal disease at presentation. Out of the remaining 393 patients, 284 (73%) had high-quality systolic and diastolic pulmonary venous recordings suitable for measurements and were included in our analysis. the mitral inflow A wave duration could be assessed as well. Table 1 shows the baseline characteristics of the 284 patients in the series, overall, and stratified by diastolic grade. The comparison shows that sex, body surface area (BSA), haemoglobin, creatinine, EF, and cardiac output were equally distributed between the groups. Systolic pulmonary vein peak velocity and integral decreased with worsening diastolic dysfunction, but diastolic flow (peak and integral) followed a bimodal trend, decreasing in mild diastolic dysfunction, normalizing in grade II diastolic dysfunction, and becoming abnormally elevated in grade III dysfunction. The combined effect of the trends in systolic and diastolic pulmonary venous flows resulted in an increase in S/D ratio (peak/peak; integral/integral) in mild diastolic dysfunction, normalization with grade II diastolic dysfunction, and markedly low ratios with severe diastolic dysfunction. The time difference between the mitral A-wave and Ar duration (DAr-A time) did not change in grades 0, I, and II but increased significantly with grade III diastolic dysfunction.
Outcome after diagnosis
There were 30 readmissions for heart failure during follow-up (7.9 + 6.9 months) after diagnosis. Thus, freedom from heart failure rates overall was 93 + 1 and 91 + 1% at 6 and 12 months, respectively. Lower peak systolic/peak diastolic pulmonary venous flow ratio and higher DAr-A time (ms) were both associated with rate of heart failure readmission (0.37 [0.14-0.99], P ¼ 0.03; 1.02 [1.01-1.03], P ¼ 0.03, respectively). The ratio of pulmonary systolic to diastolic flow integral was the best pulmonary vein flow predictor of heart failure readmission (0.3 [0.14-0.57], for each decrease in ratio, P ¼ 0.0009), better than peak systolic/peak diastolic pulmonary venous flow ratio, or DAr-A time (P , 0.01 for both). , and is free of events 3 years post-baseline echo.
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There were 48 cardiac events during follow-up. Thus, the freedom from the combined event overall was 88.6 + 1 and 83.0 + 2% at 6 and 12 months, respectively. Higher DAr-A time was significantly associated with higher rate of combined event (1.02 [1.01 -1.03], P ¼ 0.01), but not peak systolic/peak diastolic pulmonary venous flow (P ¼ 0.08). The ratio of pulmonary systolic to diastolic flow integral was the best pulmonary venous predictor of the combined event rate (0.05 [0.004 -0.5], P ¼ 0.008), superior to peak systolic/ peak diastolic pulmonary venous flow, or DA-Ar time (P , 0.01 for both).
The addition of ratio of pulmonary systolic to diastolic flow integral to diastolic grade (based on recent guidelines) showed that it has independent incremental predicting value for survival (P ¼ 0.05) and readmission for heart failure but not for the combined event ( Table 2) . Because low S/D may be a proxy for heart rate and/or LV hypertrophy we added heart rate and for LV mass index (for BSA and for height 1.7 ). The addition of heart rate and LV mass index (for BSA and height 1.7 ) to the models showed that the ratio of pulmonary systolic to diastolic flow integral has independent incremental predicting value for heart failure (P ¼ 0.05; 0.05), the combined event (P ¼ 0.05; 0.05), but not for survival (P ¼ 0.2; 0.1). The addition of DAr-A time to diastolic grade showed that it has independent incremental predicting value for readmission for heart failure but not for survival or the combined event ( Table 2) .
Effect of pulmonary venous flow on diastolic grading
A total of 108 patients (77%) out of the 141 patients classified as grade II diastolic dysfunction, based on recent guidelines, had an S/D integral ratio .1. We divided the grade II diastolic dysfunction group into patients with normal S/D peak ratio (.1), and those with lower ratio (N ¼ 33; S/D , 1) (Figure 1) . Table 3 S/D ratio remained an independent predictor of survival when adjusted for LV mass index (P ¼ 0.008), but not for LA volume index (P ¼ 0.2), E/e ′ average (P ¼ 0.2), or E/e ′ septal (0.7).
Discussion
Our study shows that pulmonary vein flow parameters are obtainable in most patients even in a busy clinical echo practice. It is the first to link pulmonary vein flow parameters to outcome in patients with preserved EF. We found that the decreased systolic to diastolic pulmonary vein flow ratio is associated with higher rates of readmission for heart failure, or a combined cardiac event even when adjusted for age, LV mass index, E/e ′ , and LA volume. The association of a grade II (pseudo-normal) mitral inflow pattern with S/D ratio .1 allows us to identify a group with a better prognostic outcome, similar to patients with grade I diastolic dysfunction and better than patients with pseudo-normal mitral inflow pattern with S/D ratio ,1.
Pulmonary vein flow parameters and outcome
Pulmonary venous findings can be divided into two groups: those related to the antegrade S and D waves, and those related to the retrograde atrial reversal wave. We found that although DAr-A time is associated with higher rate of cardiac events, the ratio of pulmonary systolic to diastolic flow integral was the best pulmonary vein flow predictor of outcome. Furthermore, only the S/D flow integral ratio had independent incremental predicting value when adjusted for LV mass index, E/e ′ , LA volume, or conventional diastolic grading. A possible reason for the superiority of the S/D flow integral ratio in our study is that interpreting DAr-A time is difficult and time consuming because of the need to obtain high-quality recordings suitable for measurements. This is especially true for Ar velocity, for which atrial contraction can create low-velocity wall motion artefacts that obscure the pulmonary flow velocity signal. 1, 10 Furthermore, sinus tachycardia and first-degree AV block often result in the start of atrial contraction occurring before diastolic mitral and pulmonary venous flow velocity has declined to the zero baseline, increasing the width of the mitral A-wave velocity and decreasing that of the reversal in the pulmonary vein, making the Ar-A relationship difficult to interpret. 1, 10 All these combined result in non-satisfactory Doppler recordings for the assessment of the Ar flow in a significant portion of patients when the exams are performed as part of a routine clinical busy echo practice. On the other hand, assessment of systolic and diastolic pulmonary vein flow is easy and was achievable in the majority of patients, increasing its statistical power.
Pulmonary vein flow and diastolic grading
The recent Joint of Diastology has recommended that an evaluation of diastolic function in patients with preserved EF begins with e ′ , LA volume index, and mitral inflow velocities, and pulmonary venous flow parameters have received only a supporting role. 1, 10 The secondary role ascribed to the pulmonary venous flow measurements was attributed to several factors including the difficulty in obtaining high-quality recordings suitable for measurements, 10,12 and the small number of studies showing the prognostic role of pulmonary venous flow, 2 -4 all performed in patients with systolic dysfunction.
In this study, we describe that the S/D ratio is obtainable in most patients with preserved EF, even when its evaluation is performed as part of a busy clinical practice. The pulmonary venous S-wave is generated not only by atrial relaxation which creates a pulmonary venous-to-left atrial pressure gradient, but also by forward propagation of the right ventricle (RV) pressure pulse and systolic descent of the AV plane. 13,14 D velocity follows the E velocity, thus is positively correlated with LA end systolic pressure (V wave) and LV active relaxation. 15 Thus, although in healthy patients a low S/D ratio may represent 'super-normal' LV relaxation, in our cohort any decrease in S/D ratio was probably related to decrease in LA relaxation, decrease in LA compliance, elevated LA pressure, decrease in LV compliance, or decrease of forward propagation of the RV pressure pulse and systolic descent of the AV plane. Based on our data we believe that Doppler pulmonary venous flow assessment has added value in the grading of diastolic dysfunction. In the majority of patients with pseudo-normal mitral inflow, although e ′ is already reduced, and LA volume is increased, S pulmonary venous velocity is still higher than D velocity, and outcome is excellent suggesting that these patients represent an intermediate stage that occurs at an early asymptomatic stage of diastolic dysfunction, with preserved LA relaxation and reservoir function.
Recent physiological studies may propose a possible explanation to these novel findings. It has been shown that e ′ becomes reduced 10-15 years earlier than the reduction of mitral inflow velocity 16 so that the pattern of reduced e ′ and normal E/A ratio in a patient with minimal diastolic dysfunction and normal LV filling pressure may resemble the grade II diastolic dysfunction pattern. Both situations have reduced e ′ and normal-appearing mitral inflow velocities. 17 The only difference might be the higher S/D ratio in this initial stage of reduced myocardial relaxation without change in the normal inflow pattern.
Conclusions
Pulmonary vein flow parameters have added prognostic value in patients with preserved EF. Diastolic dysfunction grade should take into account the systolic to diastolic pulmonary vein ratio. Patients with pseudo-normal E/A, e ′ , 8 cm/s, LA volume index ≥34 cc/m 2 , but S/D . 1 constitute a group in the diastolic dysfunction grading system with good mid-term prognosis similar to patients with Grade I diastolic dysfunction.
Study limitations
The study was not powered to assess differences in overall mortality, new onset of atrial fibrillation, or cardiac death which are rare occurrences, and therefore the analysis of this end point was limited. Therefore, we focused on heart failure re-admissions and combined cardiac events as measures of outcome because these events are associated with poor survival and represent crucial end points. Cardiac arrhythmias, especially atrial fibrillation, are a problem because of the loss of the mitral A wave, pulmonary vein atrial contraction wave, and decrease in pulmonary venous systolic flow, thus analysis of pulmonary vein flow is effective only in patients with sinus rhythm. The duration of pulmonary venous flow velocity at atrial contraction was not optimally recorded in 35% of patients and may account for the limited predictive value of the DAr-A time. Our study was a cross-sectional epidemiological study and was not designed to investigate the issue of mechanism for the favourable prognosis afforded by high S/D ratio. This is an important area for future investigation that would require a haemodynamic prospective study. Some of the patients in the group with high S/D had no, or only mild heart disease, which could have resulted in bias in the study.
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